Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person UniProt:P08519 LPA

Class:IdReferenceGeneProduct:50156
_chainChangeLogsignal peptide:1-19 added on Fri February 6 2015;chain:20-4548 added on Fri February 6 2015;chain:20-4548 for 50156 removed on Wed May 4 2022;chain:20-2040 for 50156 added on Wed May 4 2022
_displayNameUniProt:P08519 LPA
_timestamp2024-11-03 20:13:15
chainsignal peptide:1-19
chain:20-2040
checksumAC7D76CE0A0358CD
commentFUNCTION Apo(a) is the main constituent of lipoprotein(a) (Lp(a)). It has serine proteinase activity and is able of autoproteolysis. Inhibits tissue-type plasminogen activator 1. Lp(a) may be a ligand for megalin/Gp 330.SUBUNIT Disulfide-linked to apo-B100. Binds to fibronectin and decorin.INTERACTION N- and O-glycosylated. The N-glycans are complex biantennary structures present in either a mono- or disialylated state. The O-glycans are mostly (80%) represented by the monosialylated core type I structure, NeuNAcalpha2-3Galbeta1-3GalNAc, with smaller amounts of disialylated and non-sialylated O-glycans also detected.POLYMORPHISM LPA genetic variants, including variations in the number of Kringle domains, define the lipoprotein(a) quantitative trait locus (LPAQTL) and influence lipoprotein(a) levels in plasma [MIM:618807]. Depending on the individual, the encoded protein contains 2-43 copies of kringle IV-2 repeats. Often the assignement of amino acids in lipoprotein(a) is based on a long allele that contains 37 copies of the kringle-type repeats (PubMed:3670400). The reference allele represented here contains 15 copies of the kringle-type repeats.MISCELLANEOUS Apo(a) is known to be proteolytically cleaved, leading to the formation of the so-called mini-Lp(a). Apo(a) fragments accumulate in atherosclerotic lesions, where they may promote thrombogenesis. O-glycosylation may limit the extent of proteolytic fragmentation. Homology with plasminogen kringles IV and V is thought to underlie the atherogenicity of the protein, because the fragments are competing with plasminogen for fibrin(ogen) binding.SIMILARITY Belongs to the peptidase S1 family. Plasminogen subfamily.
descriptionrecommendedName: Apolipoprotein(a) shortName: Apo(a) shortName: Lp(a) ecNumber: 3.4.21.-
geneNameLPA
identifierP08519
isSequenceChangedFALSE
keyword3D-structure
Atherosclerosis
Autocatalytic cleavage
Disulfide bond
Glycoprotein
Hydrolase
Kringle
Lipid transport
Protease
Proteomics identification
Reference proteome
Repeat
Serine protease
Signal
Transport
modified[InstanceEdit:9836292] Weiser, Joel, 2023-05-25
[InstanceEdit:9852000] Weiser, Joel, 2023-11-03
[InstanceEdit:9926675] Weiser, Joel, 2024-11-03
nameLPA
referenceDatabase[ReferenceDatabase:2] UniProt
referenceGene[ReferenceDNASequence:8998739] ENSEMBL:ENSG00000198670 LPA [Homo sapiens]
secondaryIdentifierAPOA_HUMAN
Q5VTD7
Q9UD88
sequenceLength2040
species[Species:48887] Homo sapiens
(referenceEntity)[EntityWithAccessionedSequence:176877] LPA [extracellular region] [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by UniProt:P08519 LPA (50156)